Sequential Brentuximab Vedotin and AVD for Older Hodgkin Lymphoma Patients: Initial Results From a Phase 2 Multicenter Study.

Sequential Brentuximab Vedotin and AVD for Older Hodgkin Lymphoma Patients: Initial Results From a Phase 2 Multicenter Study. Clin Adv Hematol Oncol. 2015 Aug;13(8 Suppl 9):8-9 Authors: PMID: 26862872 [PubMed - in process]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research